When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Teva launches generic version of Novo Nordisk's diabetes drug ...

    www.aol.com/news/teva-launches-generic-version...

    The drug brought in annual sales of $1.66 billion as of April 2024, according to Teva. Teva's generic launch comes days after the U.S. Food and Drug Administration tentatively approved London ...

  3. 2024 United States drug shortages - Wikipedia

    en.wikipedia.org/wiki/2024_United_States_drug...

    The American Society of Health-System Pharmacists (ASHP) reported that 323 "active medication shortages" were reported in January–March 2024. As a result of drug scarcity, many healthcare systems were forced to either ration out essential drugs, triage patients based on the severity of their condition and their need for the drug, or both.

  4. 19 drug approvals in 2024 that had 'big clinical impact ... - AOL

    www.aol.com/news/19-drug-approvals-2024-had...

    GoodRx released a list of 19 of the most influential drugs and vaccines approved by the FDA in 2024 to treat a variety of conditions. These medications are “slated to make a big clinical impact."

  5. US releases preliminary list of $2 generic drugs for Medicare ...

    www.aol.com/news/biden-administration-release...

    The initial list includes common prescriptions such as penicillin, metformin, lithium and albuterol asthma inhalers, as well as drugs for high cholesterol, high blood pressure and other chronic ...

  6. Cost Plus Drugs - Wikipedia

    en.wikipedia.org/wiki/Cost_Plus_Drugs

    As of June 2022, the company had a selection of over 100 generic drugs, [7] and by March 2023, over 350 drugs were available. [8] In December 2023, the company had over 2200 drugs available. The drugs are sold for a price equivalent to the company's cost plus 15% markup, a $5 pharmacy service fee, and a $5 shipping fee.

  7. Omalizumab - Wikipedia

    en.wikipedia.org/wiki/Omalizumab

    In 1987, Tanox filed its first patent application on the anti-IgE drug candidates. It took until 2003 in the United States until omalizumab was approved, and in Europe until 2005 for moderate to severe persistent asthma and severe chronic rhinosinusitis with nasal polyps. In February 2024, the FDA approved it also to treat severe food allergy.

  8. FDA Declares Adderall Shortage Following Supply Delays

    www.aol.com/fda-declares-adderall-shortage...

    The number of Adderall and generic equivalent prescriptions has been on the rise over the past few years. In 2021, there were 41.2 million total prescriptions of the drug, a 16% increase from the ...

  9. Civica Rx - Wikipedia

    en.wikipedia.org/wiki/Civica_Rx

    Civica Rx is a nonprofit generic drug company founded in 2018 by leading U.S. health systems and philanthropies [1] for the purpose of preventing and mitigating drug shortages in the United States, and the price hikes that can accompany them. [2] Civica's mission is to make quality generic medicines accessible and affordable to everyone.